NEUROPACE INC. - COMMON STOCK

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

20 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

19 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

18 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock

14 Feb 2025 06:33:50 By Nasdaq GlobeNewswire

NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock

13 Feb 2025 16:34:21 By Nasdaq GlobeNewswire

NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th

03 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Issues 2025 Financial Guidance Targets

28 Jan 2025 17:15:59 By Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

08 Jan 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference

18 Dec 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Host Investor Day on January 28th in New York City

12 Dec 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting

04 Dec 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome

03 Dec 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

12 Nov 2024 16:05:01 By Nasdaq GlobeNewswire

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy

04 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

22 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Continues to Strengthen Management Team

16 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Strengthens Management Team with Two Key Appointments

04 Sep 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

27 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Participate in Upcoming Healthcare Conferences in September

22 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

13 Aug 2024 16:05:00 By Nasdaq GlobeNewswire